FutureCeuticals collaborates with BioBoron Research Institute to study calcium FruiteX B r fructoborato.

Momence, Illinois, August 10, 2011- / PRNewswire / – FutureCeuticals, Inc. today announced the formation of a strategic alliance with the BioBoron Research Institute and its renowned director, doctor in chemistry Ion Romulus Scorei.
The Mission of the Alliance is to advance the study and commercialization of fructoborato calcium FruiteX-B r, a complex nature identical plant mineral patented, available exclusively through FutureCeuticals, Inc.

The research of Scorei on the fructoborato of calcium has resulted in almost a dozen studies published about their unique properties and potential benefits to health, and more recently on their ability to modulate inflammatory blood markers and lipids in people with symptoms of osteoarthritis.

The new collaboration between FutureCeuticals and BioBoron Research Institute, equipped with avant-garde GMP laboratories, creates a powerful engine of discovery for the patented FruiteX-B r product. As part of the collaboration, Dr. Scorei and his team will contribute to the biological and chemical differentiation of Calcium Fructoborate from other compounds based on boron.

John M. Hunter, CEO of FutureCeuticals, said: “the Alliance with the BioBoron Research Institute and Dr. Scorei illustrates our commitment to enhance our scientific portfolio on the fructoborato of calcium, and offer greater value to our partners FruiteX-B r.” “The experience of Dr. Scorei support greatly current business initiatives and our planned push into foreign markets”.

FutureCeuticals is developing its own clinical study on the effect of FruiteX-B r on the discomfort in the joints and reduced flexibility reported by participants as well as the associated inflammatory blood markers.

On calcium FruiteX-B r fructoborato

FruiteX-B r, a revolution in nutritional supplements for support of the joints and bones, has shown modular beneficial bio-goals associated with degeneration and inflammation of joints associated with age. FruiteX-B r is manufactured under U.S. patent # 5,962,049 and has issued and outstanding foreign patents.

About Ion Romulus Scorei, PhD.

Dr. Scorei, Professor of Biochemistry at the University of Craiova, founded the BioBoron Research Institute in Romania in 2009. His work on the fructoborato of calcium has led him to receive honors with gold medal of the “Inventika International Fair”, the “International Salon of Innovation, Techniques and New Products”, and the “International Salon of Inventions and Innovations”. In 2010, Dr. Scorei received the distinction “Science Man of the Year” by the Mihai Eminescu International Academy. In addition, belongs to the Editorial Board of Biochemistry and Analytical Biochemistry: Current Research.

About FutureCeuticals, Inc.

FutureCeuticals, Inc. is a company of research and development bioanalíticos, food ingredients and product development facilities in Illinois, Wisconsin, California, and Europe.